Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cb Scientific Inc (OP: CBSC )

0.0397 UNCHANGED
Streaming Delayed Price Updated: 3:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0397
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0397
Today's Range 0.0397 - 0.0397
52wk Range 0.0270 - 0.1490
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CB Scientific, Inc. Appoints Trip Thomas as Chief Financial Officer
Via ACCESSWIRE
CB Scientific, Inc. Announces Voluntary Delisting from OTCQB Venture Market
Via ACCESSWIRE

Performance

YTD
-60.73%
-60.73%
1 Month
+19.58%
+19.58%
3 Month
-23.65%
-23.65%
6 Month
-53.29%
-53.29%
1 Year
-69.92%
-69.92%

More News

Read More
CB Scientific, Inc. Concludes its Annual Meeting of Stockholders
Via ACCESSWIRE
CB Scientific, Inc. 2023 Year in Review
Via ACCESSWIRE
CB Scientific, Inc. Announces Exclusive Canadian Distribution Agreement
Via ACCESSWIRE
CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor
Via ACCESSWIRE
CB Scientific, Inc. (CBSC) and Shenzhen Pump Medical Co., Ltd. Announce Cooperative Manufacturing Agreement for Chinese Market
Via ACCESSWIRE
CB Scientific, Inc. Enters Regulatory Testing Phase for Updated myCam Cardiac Event Monitoring Device
From CB Scientific, Inc.
Via AccessWire
Exposures Product Safety
CB Scientific, Inc. Welcomes James Ott as Chief Technology Officer
From CB Scientific, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
CB Scientific, Inc. Announces Uplist to the OTCQB(R) Venture Market
From CB Scientific, Inc.
Via AccessWire
CB Scientific, Inc. Concludes its Annual Audit with MaloneBailey, LLP
From CB Scientific, Inc.
Via AccessWire
CB Scientific, Inc. Concludes Its Special Meeting of Stockholders
From CB Scientific, Inc.
Via AccessWire
CB Scientific, Inc. to Convene a Special Meeting of Stockholders on Friday, January 14, 2022
From CB Scientific, Inc.
Via AccessWire
CB Scientific, Inc. Enters Beta-testing Phase for Its Updated Proprietary My-Cam Cardiac Event Monitor
From CB Scientific, Inc.
Via AccessWire
CB Scientific, Inc. Executes Manufacturing Letter of Intent with Shenzhen Pump Medical System Co., Ltd.
From CB Scientific, Inc.
Via AccessWire
Exposures Product Safety
Global Supplier of Non-Invasive Cardiac Monitoring Systems Expanding Via New Partnerships & OTCQB Uplisting Efforts: CB Scientific Stock Symbol: CBSC
Via Get News
Topics Supply Chain
Exposures Product Safety Supply Chain
CB Scientific, Inc. Announces Intent to Convene a Special Meeting of the Stockholders
From CB Scientific, Inc.
Via AccessWire
Exposures Product Safety
CB Scientific Files Application to Uplist to the OTCQB Venture Market
From CB Scientific, Inc.
Via AccessWire
Exposures Product Safety
CB Scientific Announces Addition of Brooke Martellaro as Chief Financial Officer
From CB Scientific, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Product Safety Regulatory
CB Scientific, Inc. Appoints Paul Danner as Chairman
From CB Scientific, Inc.
Via AccessWire
Exposures Product Safety
CB Scientific, Inc. (CBSC) Announces the Engagement of MaloneBailey, LLP
From CB Scientific, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
CB Scientific, Inc. (CBSC) Announces the Launch of Direct-to-Consumer Heart Wellness Check-Up Program in Bangkok, Thailand
From CB Scientific, Inc.
Via AccessWire
CB Scientific, Inc. (CBSC) enters into a Consultant Services Agreement with the Dorchester Group LLC
From CB Scientific, Inc.
Via AccessWire
Topics Immigration
Exposures Immigration
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.